Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph A Salami

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Circulation. Cardiovascular Quality and Outcomes|October 18, 2022
Therapeutic Inertia in Lipid-Lowering Treatment Intensification: Digital Tools and Performance Management to the Rescue?Khurram Nasir, Joseph A Salami
Journal of the American College of Cardiology|April 12, 2023
Prescription for Affordable Health Care: Promise and Perils of Inflation Reduction Act Tackling Financial ToxicityKhurram Nasir, Joseph A Salami, Elias Mossialos
JAMA Internal Medicine|August 8, 2018
Considering Pharmaceutical Rebates-ReplyHaider Warraich, Joseph A Salami, Khurram Nasir
JAMA Internal Medicine|March 12, 2018
Trends in Use and Expenditures of Brand-name Atorvastatin After Introduction of Generic AtorvastatinHaider J Warraich, Joseph A Salami, Rohan Khera, et al.
The American Journal of Medicine|October 6, 2018
Variation in the Use of Warfarin and Direct Oral Anticoagulants in Atrial Fibrillation and Associated Cost ImplicationsBenjamin A Rodwin, Joseph A Salami, Erica S Spatz, et al.
Journal of General Internal Medicine|September 7, 2019
Association of Depression Risk with Patient Experience, Healthcare Expenditure, and Health Resource Utilization Among Adults with Atherosclerotic Cardiovascular DiseaseVictor Okunrintemi, Javier Valero-Elizondo, Erin D Michos, et al.
Journal of the American Heart Association|June 11, 2017
Association Between Modifiable Risk Factors and Pharmaceutical Expenditures Among Adults With Atherosclerotic Cardiovascular Disease in the United States: 2012-2013 Medical Expenditures Panel SurveyJoseph A Salami, Javier Valero-Elizondo, Oluseye Ogunmoroti, et al.
Atherosclerosis|December 20, 2017
Persistent socioeconomic disparities in cardiovascular risk factors and health in the United States: Medical Expenditure Panel Survey 2002-2013Javier Valero-Elizondo, Jonathan C Hong, Erica S Spatz, et al.
Journal of the American Heart Association|April 25, 2018
Favorable Modifiable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs Among Cancer Patients: The 2012-2013 Medical Expenditure Panel SurveyJai Singh, Javier Valero-Elizondo, Joseph A Salami, et al.
Atherosclerosis|February 19, 2017
Favorable cardiovascular risk factor profile is associated with lower healthcare expenditure and resource utilization among adults with diabetes mellitus free of established cardiovascular disease: 2012 Medical Expenditure Panel Survey (MEPS)David I Feldman, Javier Valero-Elizondo, Joseph A Salami, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Circulation. Cardiovascular Quality and Outcomes|October 18, 2022
Therapeutic Inertia in Lipid-Lowering Treatment Intensification: Digital Tools and Performance Management to the Rescue?Khurram Nasir, Joseph A Salami
Journal of the American College of Cardiology|April 12, 2023
Prescription for Affordable Health Care: Promise and Perils of Inflation Reduction Act Tackling Financial ToxicityKhurram Nasir, Joseph A Salami, Elias Mossialos
JAMA Internal Medicine|August 8, 2018
Considering Pharmaceutical Rebates-ReplyHaider Warraich, Joseph A Salami, Khurram Nasir
JAMA Internal Medicine|March 12, 2018
Trends in Use and Expenditures of Brand-name Atorvastatin After Introduction of Generic AtorvastatinHaider J Warraich, Joseph A Salami, Rohan Khera, et al.
The American Journal of Medicine|October 6, 2018
Variation in the Use of Warfarin and Direct Oral Anticoagulants in Atrial Fibrillation and Associated Cost ImplicationsBenjamin A Rodwin, Joseph A Salami, Erica S Spatz, et al.
Journal of General Internal Medicine|September 7, 2019
Association of Depression Risk with Patient Experience, Healthcare Expenditure, and Health Resource Utilization Among Adults with Atherosclerotic Cardiovascular DiseaseVictor Okunrintemi, Javier Valero-Elizondo, Erin D Michos, et al.
Journal of the American Heart Association|June 11, 2017
Association Between Modifiable Risk Factors and Pharmaceutical Expenditures Among Adults With Atherosclerotic Cardiovascular Disease in the United States: 2012-2013 Medical Expenditures Panel SurveyJoseph A Salami, Javier Valero-Elizondo, Oluseye Ogunmoroti, et al.
Atherosclerosis|December 20, 2017
Persistent socioeconomic disparities in cardiovascular risk factors and health in the United States: Medical Expenditure Panel Survey 2002-2013Javier Valero-Elizondo, Jonathan C Hong, Erica S Spatz, et al.
Journal of the American Heart Association|April 25, 2018
Favorable Modifiable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs Among Cancer Patients: The 2012-2013 Medical Expenditure Panel SurveyJai Singh, Javier Valero-Elizondo, Joseph A Salami, et al.
Atherosclerosis|February 19, 2017
Favorable cardiovascular risk factor profile is associated with lower healthcare expenditure and resource utilization among adults with diabetes mellitus free of established cardiovascular disease: 2012 Medical Expenditure Panel Survey (MEPS)David I Feldman, Javier Valero-Elizondo, Joseph A Salami, et al.
Pageof 2